共 50 条
- [3] Screening for Age-Related Macular Degeneration: A Cost-Effectiveness Evaluation [J]. BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 31 - 41
- [6] A COST-EFFECTIVENESS ANALYSIS OF THREE TREATMENTS FOR AGE-RELATED MACULAR DEGENERATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (02): : 212 - 221
- [8] Cost-Effectiveness Models in Age-Related Macular Degeneration: Issues and Challenges [J]. PharmacoEconomics, 2016, 34 : 259 - 272
- [9] The cost-effectiveness of systematic screening for age-related macular degeneration in South Korea [J]. PLOS ONE, 2018, 13 (10):
- [10] Cost-effectiveness of ranibizumab compared with pegaptanib in neovascular age-related macular degeneration [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2010, 248 : 467 - 476